Sight Sciences, Inc.
NASDAQ: SGHT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Paul Badawi
- Employees
- 216
- Headquarters
- Menlo Park, United States
- IPO year
- 2021
- Market cap
- $299.3M
- Website
- https://www.sightsciences.com
Loading SGHT…
Loading profile data…Frequently asked questions about SGHT
What does Sight Sciences, Inc. (SGHT) do?
Sight Sciences, Inc. (SGHT) is an ophthalmic medical device firm dedicated to pioneering and bringing to market both surgical and non-surgical innovations aimed at treating various eye diseases. Its product portfolio features the OMNI Surgical System, a therapeutic instrument utilized by eye surgeons to alleviate intraocular pressure in adult gl...
Where does SGHT trade?
Sight Sciences, Inc. (SGHT) trades on the NASDAQ Global Select.
What sector is SGHT in?
Sight Sciences, Inc. (SGHT) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Sight Sciences, Inc.?
Paul Badawi is the chief executive officer of Sight Sciences, Inc. (SGHT).
Where is Sight Sciences, Inc. headquartered?
Sight Sciences, Inc. is headquartered in United States.
Does SGHT pay a dividend?
Sight Sciences, Inc. (SGHT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SGHT go public?
Sight Sciences, Inc. (SGHT) completed its initial public offering in 2021.